Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-26 @ 2:00 AM
Study NCT ID:
NCT00410605
Status:
COMPLETED
Last Update Posted:
2017-09-01
First Post:
2006-12-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-11
First Submit QC Date:
None
Study First Post Date:
2006-12-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-06-13
Results First Submit QC Date:
None
Results First Post Date:
2017-09-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-02
Last Update Post Date:
2017-09-01
Last Update Post Date Type:
ACTUAL